{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:12:39Z","timestamp":1776107559143,"version":"3.50.1"},"reference-count":20,"publisher":"BMJ","issue":"6505","license":[{"start":{"date-parts":[[1985,11,9]],"date-time":"1985-11-09T00:00:00Z","timestamp":500342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1985,11,9]]},"abstract":"<jats:p>In a multicentre, randomised, prospective trial 89 patients (67 children and 22 adults) with the minimal change nephrotic syndrome were treated with three intravenous pulses of methylprednisolone followed by low dose oral prednisone for six months (group given methylprednisolone) or with high dose oral prednisone for four weeks followed by low dose oral prednisone for five months (control group). Five patients in the group given methylprednisolone and one in the control group did not respond initially. The time to response was shorter in children treated with methylprednisolone. No significant differences between the two groups were observed in the number of patients who relapsed or number of relapses per patient per year. Patients given methylprednisolone tended to relapse earlier than patients in the control group. Side effects related to treatment were significantly fewer in the group given methylprednisolone than in the control group. These data suggest that a short course of methylprednisolone pulses followed by low dose oral prednisone is only marginally less effective than a regimen of high dose oral steroids but can improve the ratio of risk to benefit associated with treatment of the minimal change nephrotic syndrome.<\/jats:p>","DOI":"10.1136\/bmj.291.6505.1305","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"1305-1308","source":"Crossref","is-referenced-by-count":68,"title":["Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome."],"prefix":"10.1136","volume":"291","author":[{"given":"E","family":"Imbasciati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gusmano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Edefonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Zucchelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Della Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Perfumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Petrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Picca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1985,11,9]]},"reference":[{"key":"ref_1","first-page":"1353","article-title":"Clinicopathological study of nephrotic syndrome in childhood","volume":"i:","author":"RHR, I.White; EF, Glasgow; Rj, Mills","year":"1970","unstructured":"I White RHR, Glasgow EF, Mills Rj. Clinicopathological study of nephrotic syndrome in childhood. Lancet 1970;i:1353-9.","journal-title":"Lancet"},{"key":"ref_2","first-page":"461","article-title":"'T'he nephrotic syndrome in adults with 'minimal change' glomerular lesions","volume":"171","author":"Cameron, J.S.; T'urner, D.R.; Ogg, C.S.; Sharpstone, P.; Brown, C.B.","year":"1974","unstructured":"Cameron JS, T'urner DR, Ogg CS, Sharpstone P, Brown CB. 'T'he nephrotic syndrome in adults with 'minimal change' glomerular lesions. QJ Med 1974;171:461-88.","journal-title":"QJ Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","article-title":"Long term outcome of primary nephrotic syndrome","volume":"57","year":"1982","unstructured":"Koskimies 0, Vilska J, Rapola J, Hallman N. Long term outcome of primary nephrotic syndrome. Arch Dis Child 1982;57:544-8.","journal-title":"Arch Dis Child"},{"key":"ref_4","first-page":"401","article-title":"Alternate day versus intermittent prednisone in frequently relapsing nephrotic svndrome","volume":"i:","author":"Arbeitsgemeinschaft fur Padiatrische Nephrologie","year":"1979","unstructured":"Arbeitsgemeinschaft fur Padiatrische Nephrologie. Alternate day versus intermittent prednisone in frequently relapsing nephrotic svndrome. Lancet 1979;i:401-3.","journal-title":"Lancet"},{"key":"ref_5","first-page":"685","article-title":"Intravenous methylprednisolone in minimal change nephrotic syndrome","volume":"280","author":"Ponticelli, C.; Zucchelli, P.; Imbasciati, E.; Cagnoli, L.","year":"1980","unstructured":"Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L. Intravenous methylprednisolone in minimal change nephrotic syndrome. Br Med7 1980;280:685."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ki.1979.104","article-title":"Relapsing nephrotic syndrome in childhood","volume":"16","author":"Gmpe, W.E.","year":"1979","unstructured":"Gmpe WE. Relapsing nephrotic syndrome in childhood. Kidney Int 1979;16:75-85.","journal-title":"Kidney Int"},{"key":"ref_7","first-page":"561","article-title":"Identification of patients with minimal change nephrotic syndrome from initial response to prednisone","volume":"98","year":"1981","unstructured":"Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. 7 Pedtatr 1981;98:561-4."},{"key":"ref_8","first-page":"111","article-title":"Non parametinc statistics","author":"Siegel, S.","year":"1956","unstructured":"Siegel S. Non parametinc statistics. Tokyo: McGraw-Hill, Kogakusha, 1956:111-6."},{"key":"ref_9","first-page":"226","article-title":"Clinical trials: practical approach","author":"Pocock, S.J.","year":"1983","unstructured":"Pocock SJ. Clinical trials: practical approach. Chichester: Wiley, 1983:226-7."},{"key":"ref_10","first-page":"1","article-title":"Design and analysis of randomised clinical trials requiring prolonged observation of each patient","volume":"35","author":"Peto, R.; Pike, M.C.; Armuitage, P.","year":"1977","unstructured":"Peto R, Pike MC, Armuitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br] Cancer 1977;35:1-39.","journal-title":"II. Analysis and examples. Br] Cancer"},{"key":"ref_11","first-page":"55","article-title":"Late development of chronic renal failure in steroidresponsive nephrotic syndrome","volume-title":"Pediatr 1982; 101: 411-4. 12 'Trainin EB, Gomez-Leon G. Development of renal insufficiency after long-standing steroid responsive nephrotic syndrome","volume":"3","author":"Nash, M.A.; Bakare, M.A.; d'Agati, V.; Pirani, C.","year":"1982","unstructured":"Nash MA, Bakare MA, d'Agati V, Pirani C. Late development of chronic renal failure in steroidresponsive nephrotic syndrome. 7 Pediatr 1982;101:411-4. 12 'Trainin EB, Gomez-Leon G. Development of renal insufficiency after long-standing steroid responsive nephrotic syndrome. Int 7Pedtatr Nephrol 1982;3:55-8."},{"issue":"765-7","key":"ref_12","first-page":"1","article-title":"International Study of Kidney Disease in Children. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity","volume":"20","year":"1981","unstructured":"International Study of Kidney Disease in Children. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 1981;20:765-7 1.","journal-title":"Kidney Int"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0002-9343(81)90538-6","article-title":"High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus","volume":"70","author":"Kimberly, R.P.; Lockshin, M.D.; Sherman, R.L.; McDouglas, J.S.; Inman, R.D.; Christian, C.L.","year":"1981","unstructured":"Kimberly RP, Lockshin MD, Sherman RL, McDouglas JS, Inman RD, Christian CL. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med 1981;70:817-24.","journal-title":"Am J Med"},{"key":"ref_14","first-page":"16","article-title":"Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone","author":"Ponticelli, C.; Zucchelli, P.; Banfi, G.","year":"1982","unstructured":"Ponticelli C, Zucchelli P, Banfi G, et al. Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone. Q Med 1982;201:16-24.","journal-title":"Q Med"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0002-9343(79)91081-7","article-title":"Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis","volume":"66","author":"Bolton, W.K.; Couser, W.G.","year":"1979","unstructured":"Bolton WK, Couser WG. Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis. Am] Med 1979;66:495-502.","journal-title":"Am] Med"},{"key":"ref_16","first-page":"221","article-title":"Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy","volume":"19","author":"A, De Vecchi; G, Montagnino; C, Pozzi; A, Tarantino; F, Locatelli; C, Ponticelli","year":"1983","unstructured":"De Vecchi A, Montagnino G, Pozzi C, Tarantino A, Locatelli F, Ponticelli C. Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. Clin Nephrol 1983;19:221-7.","journal-title":"Clin Nephrol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM198404123101503","article-title":"Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"310","author":"Ponticelli, C.; Zucchelli, P.; Imbasciati, E.","year":"1984","unstructured":"Ponticelli C, Zucchelli P, Imbasciati E, et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N EngI] Med 1984;310:946-50.","journal-title":"N EngI] Med"},{"key":"ref_18","first-page":"588","article-title":"Adult-onset nephrotic syndrome with minimal change: response to corticosteroids and cyclophosphamide","volume-title":"PJ, eds. Proc EDTA-ERA","author":"Nolasco, F.; Cameron, J.S.; Hicks, J.; Ogg, C.S.; Williams, D.G.","year":"1984","unstructured":"Nolasco F, Cameron JS, Hicks J, Ogg CS, Williams DG. Adult-onset nephrotic syndrome with minimal change: response to corticosteroids and cyclophosphamide. In: Davison AM, Guillon PJ, eds. Proc EDTA-ERA (1984). London: Pitman, 1985:588-93."},{"key":"ref_19","first-page":"423","article-title":"International Study of Kidney Disease in Children. Prospective controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome","volume":"ii:","year":"1974","unstructured":"International Study of Kidney Disease in Children. Prospective controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 1974;ii:423-7.","journal-title":"Lancet"},{"key":"ref_20","year":"1985","unstructured":"(Accepted 13 August 1985)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.291.6505.1305","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.291.6505.1305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:12:58Z","timestamp":1765480378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.291.6505.1305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,11,9]]},"references-count":20,"journal-issue":{"issue":"6505","published-online":{"date-parts":[[1985,11,9]]},"published-print":{"date-parts":[[1985,11,9]]}},"alternative-id":["10.1136\/bmj.291.6505.1305"],"URL":"https:\/\/doi.org\/10.1136\/bmj.291.6505.1305","relation":{},"ISSN":["0267-0623","1468-5833"],"issn-type":[{"value":"0267-0623","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,11,9]]}}}